Compare FedEx Corporation (FDX) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs HCA Health Inc — how do they compare? FedEx Corporation trades at $318.64 (market cap $74.78B), while HCA Health Inc trades at $386.18 (market cap $84.04B). The key difference: FedEx Corporation and HCA Health Inc are close in size by market cap, and FedEx Corporation pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| FDX | HCA | |
|---|---|---|
Market Cap | $74.78B | $84.04B |
Sector | Industrials | Health |
52-Week High | $338.75 | $545.13 |
52-Week Low | $174.81 | $334.32 |
Enterprise Value | $104.42B | $132.95B |
Dividend Yield | 1.56% | 0.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FedEx (FDX) trades at $316.24, up 0.82% on the day, with a bearish technical signal despite recent earnings beats. The company shows steady revenue near $88B and net income of $4.09B in 2025, supported by a P/E of 16.9 and strong analyst consensus. Recent developments include the sale of FedEx Supply Chain for $1.4B and a $4.15B debt tender offer, enhancing financial flexibility.
The outlook is mixed: cost-cutting initiatives and strategic divestitures provide upside, but competitive pressures from Amazon and soft shipping demand pose risks. With 57% of analysts rating it Buy and a $360.27 price target, the stock offers potential appreciation if margin recovery aligns with guidance, though execution remains key.
HCA Healthcare (HCA) trades at $389.90, up 7.23% over the past 24 hours, with strong recent earnings beats but a bearish technical signal. The stock shows solid fundamentals with 2025 revenue of $75.60B and net income of $6.78B, supported by a P/E of 13.05 and net margin of 8.89%. However, recent news highlights guidance cuts due to payer mix shifts and rising uninsured patients, creating near-term headwinds.
The outlook is mixed: analyst consensus remains bullish with a $469.40 price target, but technical indicators and recent guidance reductions suggest caution. Key risks include margin compression and debt levels, while long-term growth drivers like capacity expansion and gene therapy research offer potential upside. Investors should weigh strong valuation metrics against operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
